American Hospital Association CEO to retire
Rick Pollack, who has served as leader of the hospital lobby since 2015, will retire by the end of next year. The AHA will conduct a nationwide search for his replacement.
Rick Pollack, who has served as leader of the hospital lobby since 2015, will retire by the end of next year. The AHA will conduct a nationwide search for his replacement.
Companies can ask the FDA to waive premarket authorization and investigational device requirements while they collect real-world data in a CMS program.
FDA pilots allowing digital health devices access to CMS payment program Read More »
The Commissioner’s National Priority Voucher program was launched in June to shorten review times for companies that align with various national priorities, such as improving domestic drug production and supply.
First Commissioner’s Priority Review Approval Goes to Decades-Old Antibiotic Read More »
Foresight’s technology will be integrated into Natera’s Signatera platform and is expected to be launched for clinical use in 2026.
Natera acquires Foresight Diagnostics for up to $450M Read More »
Needham analysts said Teleflex’s inability to secure a price above the low end of their expectations could reflect “the continued poor performance of UroLift.”
Teleflex inks deals to sell 3 businesses for $2B Read More »
Some 5.8 million people have signed up for 2026 ACA plans so far, up about 7% year over year. Still, enrollment tends to shift over signup periods, so it’s too early to conclude that the Obamacare exchanges won’t shrink next year.
Early ACA enrollment holds steady despite subsidy turmoil Read More »
CVS is bringing together its disparate businesses onto one platform, and giving its rivals the option to add their products and services as well. The goal is to improve consumers’ health engagement while generating more revenue.
CVS to launch ‘engagement’ platform in gamble on consumer, industry interest Read More »
The legislation, which is scheduled for a vote Thursday, would send funds directly to health savings accounts paired with bronze or catastrophic plans offered on the Affordable Care Act exchanges.
Crapo, Cassidy propose enhanced ACA subsidy alternative Read More »
The Commissioner’s National Priority Voucher program was launched in June to shorten review times for companies that align with various national priorities, such as improving domestic drug production and supply.
First Commissioner’s Priority Review Approval Goes to GSK’s Decades-Old Antibiotic Read More »
The FDA has informed Merck, Sanofi and AstraZeneca of the safety investigation into their RSV antibodies, though it remains unclear what regulatory action, if any, will be taken.
FDA Launches Probe Into Safety of Approved Anti-RSV Antibodies Read More »